Covid 19 where are we with a vaccine? Some 20 biotechnology companies and organisations are racing against the clock to find a vaccine as the coronavirus spreads. Most of them are in the US, Europe and China.
Massachussets-based company Moderna is testing its first vaccines against Covid-19 in the US and has taken the lead - for now...while Chinese scientists are researching multiple types of vaccines simultaneously in hospitals and universities across the country.
• United States
Moderna
Vaccine: "mRNA-1273"
1st clinical test in Seattle on March 16th on 45 healthy patients
Forecast: Available in 12-18 months if efficient
(Source: Food and Drug administration/FDA)
Gilead Sciences
"Remdesivir" could be the first treatment on the market
Used to treat Ebola but not efficient
Forecast: Available in the coming months
(Source: Bruce Aylward, World Health Organization/WHO)
Inovio Pharmaceuticals
DNA vaccine
Fist clinical tests in April in the US, then in China and South Korea
Forecast: delivering 1 million doses by the end of the year
(Source: J. Joseph Kimn, CEO Inovio)
• Germany
CureVac
DNA vaccine
The European Commission offered 80 million euros to CureVac on 17 March to develop the vaccine
A candidate vaccine could be provided within a few months
(Source: CEO, CureVac)
• France
France is to increase its scientific research budget by five billion euros over the next ten years
Pasteur Institute
Use of measles vaccine
Forecast: first vaccine by fall 2020
Pasteur Institute to be given 5 million euros to develop vaccine
(Source: Pasteur Institute)
Sanofi
In cooperation with US Health Ministry
DNA vaccine
Possible clinical test within 12-18 months
(Source: David Loew, Vice-president Sanofi Pasteur)
IHU – Institut hospitalo-universitaire
Treatment with chloroquine (anti-malaria drug)
Has been testing since 9 March on 24 patients; after 6 days, only 25% of patients are still infected (Source: Pr. Didier Raoult, IHU Director)
French Health ministry expresses methodological concerns but has given green light to larger clinical tests
Sanofi has offered 300,000 anti-malaria doses if proven efficient
• China
Clover Biopharmaceuticals
Chengdu-based
Partnership with GSK (Bratford, UK)
GSK will provide Clover with its proprietary adjuvants
Chinese scientists researching multiple types of vaccines simultaneously
Some have entered animal trials (mice)
Forecast: first clinical trials in late April 2020
(Source: Chinese National Health Commission)
• Japan
Fujifilm Biotechnologies
Flu shot treatment Avigan
Tested on board of the Diamond Princess ship cruise when in quarantine
Clinical tests on 200 patients in Wuhan and Shenzen, China
(Source: Chinese National Health Commission)
Elisabeth Borne has been to the National Assembly on her first full day as French Prime Minister. She spoke at a meeting of LREM deputies this morning...
Read More
A man is in a serious condition after an accident with a chainsaw. The accident for which the exact circumstances remain unclear, occurred this mornin...
Read More
The President of the Auvergne-Rhone-Alpes region Laurent Wauquiez has announced that the region is to withdraw its subsidies to the city council of Gr...
Read More
According to figures published today by INSEE the unemployment rate in France is almost stable in the first quarter of 2022 at 7.3% compared to 7.4% i...
Read More
Three weeks after Emmanuel Macron’s victory in the second round of elections France has a new Prime Minister, Elisabeth Borne. Appointed on Monday eve...
Read More
